KM plot analyses from the same dataset revealed that GC patients with high ESM1 tumor expression had shorter overall survival (OS) (p = 0.011) and disease-free survival (DFS) (p = 0.042) times compared to those with low ESM1 tumor expression (Figure 1D). This evidence concerns the gene ESM1 and gastric cancer.